Acrongenomics Inc.

Acrongenomics Inc. of Geneva and Molecular Visions Ltd. of London will combine efforts to develop and commercialize portable point-of-care diagnostic equipment for medical testing. Potential tests include those for diagnosing diabetes, drug abuse, sexually transmitted diseases and cardiovascular diseases. The partnership will draw on the British company’s patented diagnostic chips, technology that incorporates microfluidics and organic semiconductor devices.





LATEST NEWS

• CLEO Heads to the East Coast
  Apr 29, 2024
• Laser-Based Gas Analyzer Developed to Detect Air Pollution
  Apr 29, 2024
• Qubits Could be Stored in Flash-Like Memory
  Apr 29, 2024
• Exail Signs LLNL Contract, Partners with Eelume
  Apr 26, 2024
• Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
  Apr 26, 2024
• Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
  Apr 25, 2024
• DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
  Apr 25, 2024
• Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
  Apr 24, 2024